Central Pharmaceutical JSC No3
Central Pharmaceutical JSC No3 operates in Pharmaceuticals.
Central Pharmaceutical JSC No3 (DP3) - Net Assets
Latest net assets as of : ₫- VND
Based on the latest financial reports, Central Pharmaceutical JSC No3 (DP3) has net assets worth ₫- VND as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫-) and total liabilities (₫-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₫- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Central Pharmaceutical JSC No3 - Net Assets Trend (None–None)
This chart illustrates how Central Pharmaceutical JSC No3's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Central Pharmaceutical JSC No3 (None–None)
The table below shows the annual net assets of Central Pharmaceutical JSC No3 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Central Pharmaceutical JSC No3's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Central Pharmaceutical JSC No3 Competitors by Market Cap
The table below lists competitors of Central Pharmaceutical JSC No3 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TF665
SA:TF665
|
$24.33K |
|
ANGLO ASIAN MINING - Frankfurt Stock Exchang
F:A4A
|
$24.35K |
|
FrankSpeech Network, Inc.
PINK:INCTD
|
$24.35K |
|
RIVER+MERC.UK MIC.RED PR
F:3RM0
|
$24.41K |
|
UNISYS
BE:USY1
|
$24.30K |
|
PARK & BELLH (PKB.SG)
STU:PKB
|
$24.25K |
|
Colipays Reunion SA
PA:MLCLP
|
$24.24K |
|
DAR ES SALAAM STOCK EXCHANGE PLC
DSE:DSE
|
$24.24K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Central Pharmaceutical JSC No3's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Central Pharmaceutical JSC No3's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Central Pharmaceutical JSC No3 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Central Pharmaceutical JSC No3's net assets metrics with peer companies in the Pharmaceuticals industry.
No peer company data available for comparison.